vs

Side-by-side financial comparison of Katapult Holdings, Inc. (KPLT) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.

Katapult Holdings, Inc. is the larger business by last-quarter revenue ($73.9M vs $57.3M, roughly 1.3× RHYTHM PHARMACEUTICALS, INC.). Katapult Holdings, Inc. runs the higher net margin — 26.8% vs -83.0%, a 109.8% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 17.3%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 6.6%).

Katapult Holdings, Inc. is a U.S.-based fintech company that provides accessible point-of-sale lease-to-purchase solutions for consumers with limited or no traditional credit history. It partners with a wide network of e-commerce platforms and brick-and-mortar retail merchants across segments including electronics, furniture and home goods to offer flexible payment plans for customers to obtain needed products.

Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.

KPLT vs RYTM — Head-to-Head

Bigger by revenue
KPLT
KPLT
1.3× larger
KPLT
$73.9M
$57.3M
RYTM
Growing faster (revenue YoY)
RYTM
RYTM
+19.5% gap
RYTM
36.9%
17.3%
KPLT
Higher net margin
KPLT
KPLT
109.8% more per $
KPLT
26.8%
-83.0%
RYTM
Faster 2-yr revenue CAGR
RYTM
RYTM
Annualised
RYTM
48.5%
6.6%
KPLT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
KPLT
KPLT
RYTM
RYTM
Revenue
$73.9M
$57.3M
Net Profit
$19.8M
$-47.5M
Gross Margin
15.6%
91.6%
Operating Margin
-1.4%
-82.2%
Net Margin
26.8%
-83.0%
Revenue YoY
17.3%
36.9%
Net Profit YoY
307.3%
-9.6%
EPS (diluted)
$3.69
$-0.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KPLT
KPLT
RYTM
RYTM
Q4 25
$73.9M
$57.3M
Q3 25
$74.0M
$51.3M
Q2 25
$71.9M
$48.5M
Q1 25
$71.9M
$32.7M
Q4 24
$63.0M
$41.8M
Q3 24
$60.3M
$33.3M
Q2 24
$58.9M
$29.1M
Q1 24
$65.1M
$26.0M
Net Profit
KPLT
KPLT
RYTM
RYTM
Q4 25
$19.8M
$-47.5M
Q3 25
$-4.9M
$-52.9M
Q2 25
$-7.8M
$-46.6M
Q1 25
$-5.7M
$-49.5M
Q4 24
$-9.6M
$-43.3M
Q3 24
$-8.9M
$-43.6M
Q2 24
$-6.9M
$-32.3M
Q1 24
$-570.0K
$-141.4M
Gross Margin
KPLT
KPLT
RYTM
RYTM
Q4 25
15.6%
91.6%
Q3 25
19.7%
89.3%
Q2 25
15.5%
88.6%
Q1 25
19.9%
88.8%
Q4 24
11.8%
90.9%
Q3 24
19.8%
88.5%
Q2 24
16.9%
89.9%
Q1 24
25.3%
89.2%
Operating Margin
KPLT
KPLT
RYTM
RYTM
Q4 25
-1.4%
-82.2%
Q3 25
3.3%
-102.6%
Q2 25
-2.0%
-93.4%
Q1 25
-0.7%
-143.7%
Q4 24
-7.7%
-98.6%
Q3 24
-7.4%
-132.0%
Q2 24
-4.5%
-139.2%
Q1 24
5.8%
-538.7%
Net Margin
KPLT
KPLT
RYTM
RYTM
Q4 25
26.8%
-83.0%
Q3 25
-6.7%
-103.1%
Q2 25
-10.9%
-96.1%
Q1 25
-7.9%
-151.4%
Q4 24
-15.2%
-103.6%
Q3 24
-14.7%
-131.2%
Q2 24
-11.7%
-110.9%
Q1 24
-0.9%
-544.4%
EPS (diluted)
KPLT
KPLT
RYTM
RYTM
Q4 25
$3.69
$-0.73
Q3 25
$-0.94
$-0.82
Q2 25
$-1.63
$-0.75
Q1 25
$-1.23
$-0.81
Q4 24
$-2.17
$-0.71
Q3 24
$-2.05
$-0.73
Q2 24
$-1.61
$-0.55
Q1 24
$-0.13
$-2.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KPLT
KPLT
RYTM
RYTM
Cash + ST InvestmentsLiquidity on hand
$22.4M
$388.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$-38.1M
$139.1M
Total Assets
$107.9M
$480.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KPLT
KPLT
RYTM
RYTM
Q4 25
$22.4M
$388.9M
Q3 25
$3.4M
$416.1M
Q2 25
$3.7M
$291.0M
Q1 25
$6.0M
$314.5M
Q4 24
$3.5M
$320.6M
Q3 24
$25.9M
$298.4M
Q2 24
$33.7M
$319.1M
Q1 24
$31.2M
$201.2M
Stockholders' Equity
KPLT
KPLT
RYTM
RYTM
Q4 25
$-38.1M
$139.1M
Q3 25
$-58.4M
$148.8M
Q2 25
$-54.1M
$-11.9M
Q1 25
$-51.7M
$18.9M
Q4 24
$-46.8M
$21.7M
Q3 24
$-40.3M
$11.2M
Q2 24
$-32.9M
$39.3M
Q1 24
$-27.5M
$61.6M
Total Assets
KPLT
KPLT
RYTM
RYTM
Q4 25
$107.9M
$480.2M
Q3 25
$85.9M
$506.9M
Q2 25
$90.6M
$372.7M
Q1 25
$88.5M
$386.7M
Q4 24
$93.2M
$392.3M
Q3 24
$92.0M
$363.6M
Q2 24
$106.6M
$381.8M
Q1 24
$106.6M
$258.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KPLT
KPLT
RYTM
RYTM
Operating Cash FlowLast quarter
$-11.9M
$-25.4M
Free Cash FlowOCF − Capex
$-12.0M
FCF MarginFCF / Revenue
-16.2%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
-0.60×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KPLT
KPLT
RYTM
RYTM
Q4 25
$-11.9M
$-25.4M
Q3 25
$4.0M
$-26.6M
Q2 25
$-6.6M
$-23.3M
Q1 25
$3.4M
$-40.4M
Q4 24
$-32.6M
$-18.8M
Q3 24
$-5.4M
$-25.2M
Q2 24
$-628.0K
$-29.1M
Q1 24
$2.0M
$-40.7M
Free Cash Flow
KPLT
KPLT
RYTM
RYTM
Q4 25
$-12.0M
Q3 25
$4.0M
Q2 25
Q1 25
$3.4M
Q4 24
$-32.6M
Q3 24
$-5.4M
Q2 24
$-653.0K
Q1 24
FCF Margin
KPLT
KPLT
RYTM
RYTM
Q4 25
-16.2%
Q3 25
5.4%
Q2 25
Q1 25
4.7%
Q4 24
-51.8%
Q3 24
-9.0%
Q2 24
-1.1%
Q1 24
Capex Intensity
KPLT
KPLT
RYTM
RYTM
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.0%
Q4 24
0.1%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
KPLT
KPLT
RYTM
RYTM
Q4 25
-0.60×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons